Top

Published in:

Open Access 01-12-2015 | Case report

A case of tuberous sclerosis complex with concomitant primary hyperparathyroidism due to parathyroid adenoma: a case report

Authors: Yuji Shinzato, Yasukazu Ikehara

Published in: World Journal of Surgical Oncology | Issue 1/2015

Abstract

The patient was a 27-year-old woman who was clinically diagnosed with tuberous sclerosis complex (TSC). She developed hypercalcemia and hypophosphatemia at age 23. In a detailed examination at age 26, she was diagnosed with primary hyperparathyroidism due to parathyroid adenoma. After undergoing parathyroidectomy, her hypercalcemia and hypophosphatemia rapidly normalized. Subsequent genetic testing revealed mutations of the TSC1 gene. TSC with concomitant parathyroid adenoma is extremely rare; only three cases have been reported worldwide. However, each of these cases was diagnosed clinically. Therefore, our case is the first to be diagnosed with genetic testing.

Curatolo P, Maria BL. Tuberous sclerosis. Handb Clin Neurol. 2013;111:323–31.CrossRefPubMed

Yin W, Zhu DM, Wang DS, Wang DX, Wu EH, Zhu XY. Parathyroid adenoma with primary hyperparathyroidism and tuberous sclerosis. A case report. Chin Med J. 1984;97:599–602.PubMed

Ilgren EB, Westmoreland D. Tuberous sclerosis: unusual association in four cases. J Clin Pathol. 1984;37:272–8.CrossRefPubMedCentralPubMed

Mortensen LS, Rungby J. Tuberous sclerosis and parathyroid adenoma. J Clin Pathol. 1991;44:961–2.CrossRefPubMedCentralPubMed

National Institute of Neurological Disorders and Stroke (NINDS). National Institute of Health (NIH). Tuberous Sclerosis Fact Sheet. 2015. http://www.ninds.nih.gov/disorders/tuberous_sclerosis. Accessed 17 Feb 2015.

Japan Intractable Research Foundation. Japan Intractable Diseases Information Center. 2014. http://www.nanbyou.or.jp. Accessed 17 Feb 2015. [in Japanese]

Obara T. Diagnosis and treatment of primary-hyperparathyroidism. Nihon Naibunpi Gakkai Zasshi. 1992;68:1167–76 [in Japanese].PubMed

Knudson Jr AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971;68:820–3.CrossRefPubMedCentralPubMed

Sepp T, Yates JR, Green AJ. Loss of heterozygosity in tuberous sclerosis hamartomas. J Med Genet. 1996;33:962–4.CrossRefPubMedCentralPubMed

10.

Ouyang T, Zhang N, Benjamin T, Wang L, Jiao J, Zhao Y, et al. Subependymal giant cell astrocytoma: current concepts, management, and future directions. Childs Nerv Syst. 2014;30:561–70.CrossRefPubMed

11.

Green AJ, Smith M, Yates JR. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet. 1994;6:193–6.CrossRefPubMed

12.

Carbonara C, Longa L, Grosso E, Borrone C, Garrè MG, Brisigotti M, et al. 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene. Hum Mol Genet. 1994;3:1829–32.CrossRefPubMed

13.

Henske EP, Scheithauer BW, Short MP, Wollmann R, Nahmias J, Hornigold N, et al. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet. 1996;59:400–6.PubMedCentralPubMed

14.

Huang J, Manning BD. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J. 2008;412:179–90.CrossRefPubMedCentralPubMed

15.

Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006;355:1345–56.CrossRefPubMed

16.

Curatolo P, Moavero R. mTOR Inhibitors in tuberous sclerosis complex. Curr Neuropharmacol. 2012;10:404–15.CrossRefPubMedCentralPubMed

17.

Budde K, Gaedeke J. Tuberous sclerosis complex-associated angiomyolipomas: focus on mTOR inhibition. Am J Kidney Dis. 2012;59:276–83.CrossRefPubMed

18.

Dworakowska D, Grossman AB. Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review. Endocr Relat Cancer. 2009;16:45–58.CrossRefPubMed

19.

Díaz Díaz D, Ibarrola C, Goméz Sanz R, Pérez Hurtado B, Salazar Tabares J, Colina Ruizdelgado F. Neuroendocrine tumor of the pancreas in a patient with tuberous sclerosis: a case report and review of the literature. Int J Surg Pathol. 2012;20:390–5.CrossRefPubMed

20.

Jiao Y, Shi C, Edil BH, de Wilde RF, Klimstra DS, Maitra A, et al. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science. 2011;331:1199–203.CrossRefPubMedCentralPubMed

Title: A case of tuberous sclerosis complex with concomitant primary hyperparathyroidism due to parathyroid adenoma: a case report
Authors: Yuji Shinzato
Yasukazu Ikehara
Publication date: 01-12-2015
Publisher: BioMed Central
Published in: World Journal of Surgical Oncology / Issue 1/2015
Electronic ISSN: 1477-7819
DOI: https://doi.org/10.1186/s12957-015-0520-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A case of tuberous sclerosis complex with concomitant primary hyperparathyroidism due to parathyroid adenoma: a case report

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2015

The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer

Two cases of pineal-region meningiomas derived from arachnoid membrane over the vein of Galen without dural attachment

The role of lymph nodes in predicting the prognosis of ampullary carcinoma after curative resection

A case of marginal zone B cell lymphoma mimicking IgG4-related dacryoadenitis and sialoadenitis

Large hemangiopericytoma of the pelvis—towards a multidisciplinary approach

Primary tumors of the patella